Proton pump inhibitors do not contribute to dementia or Alzheimer's disease
Recently, safety questions about these medications have been raised in several studies. These studies suggested that PPIs increased the risk for dementia and Alzheimer's disease in people 75-years-old or older. Noting that the prescription of PPIs is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease. They published their study in the Journal of the American Geriatrics Society . The researchers also examined whether people with mild cognitive impairment who took PPIs were at higher risk for developing dementia or Alzheimer's disease. The researchers examined information from the National Alzheimer's Coordinating Center (NACC) database for 2005 through 2015. Data came from people who were 50-years-old or older and had either normal brain function (their scores on cognitive tests were normal and they could perform everyday activities) o...